Penserra Capital Management LLC increased its stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 7.8% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 1,122,813 shares of the company’s stock after acquiring an additional 81,010 shares during the quarter. Penserra Capital Management LLC’s holdings in BlackRock Health Sciences Term Trust were worth $16,729,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Raymond James Financial Inc. bought a new position in BlackRock Health Sciences Term Trust in the 4th quarter worth about $10,869,000. Absolute Investment Advisers LLC boosted its holdings in shares of BlackRock Health Sciences Term Trust by 112.7% in the first quarter. Absolute Investment Advisers LLC now owns 582,256 shares of the company’s stock valued at $8,676,000 after purchasing an additional 308,562 shares during the period. CF Capital LLC bought a new position in BlackRock Health Sciences Term Trust in the fourth quarter worth approximately $3,743,000. Bank of America Corp DE increased its holdings in BlackRock Health Sciences Term Trust by 10.9% during the 4th quarter. Bank of America Corp DE now owns 1,355,347 shares of the company’s stock worth $19,517,000 after purchasing an additional 132,926 shares during the period. Finally, Sit Investment Associates Inc. raised its position in BlackRock Health Sciences Term Trust by 7.9% during the 4th quarter. Sit Investment Associates Inc. now owns 1,724,706 shares of the company’s stock valued at $24,836,000 after purchasing an additional 125,599 shares in the last quarter.
BlackRock Health Sciences Term Trust Trading Down 0.1%
Shares of BMEZ stock opened at $14.46 on Friday. BlackRock Health Sciences Term Trust has a twelve month low of $12.58 and a twelve month high of $16.75. The stock has a fifty day simple moving average of $14.44 and a two-hundred day simple moving average of $14.90.
BlackRock Health Sciences Term Trust Cuts Dividend
BlackRock Health Sciences Term Trust Company Profile
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Recommended Stories
- Five stocks we like better than BlackRock Health Sciences Term Trust
- How to Invest in the Best Canadian Stocks
- Correction Equals Opportunity in Domino’s Pizza Stock
- What Are the U.K. Market Holidays? How to Invest and Trade
- 3 Defense Leaders Set to Gain From Rising Military Spend
- What is an Earnings Surprise?
- Why the Schwab Dividend ETF Rallied—and Can It Keep Climbing?
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.